Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 24446561.
- Also identified by PMC identifier 4339110.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hybrid coronary revascularization (HCR) combines bypass grafting of the left anterior descending (LAD) coronary artery with percutaneous coronary intervention (PCI) of non-LAD vessels. HCR has been performed as an alternative to CABG or multi-vessel PCI in thousands of patients since the late 1990s. In this review article, we provide an overview on patient selection, procedural sequence and timing, use of surgical techniques and anti-platelet agents. Additionally, patient recovery, satisfaction, costs and clinical outcomes of individual studies after HCR are evaluated. Future directions are also discussed, including the need for adequately powered randomized trials.
Medical subject headings
- Coronary Artery Disease
- Patient Selection
- Percutaneous Coronary Intervention